TickerFacts.

Compare

Prestige Consumer Healthcare Inc. vs Madrigal Pharmaceuticals, Inc. vs Indivior Pharmaceuticals, Inc. vs ANI Pharmaceuticals Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearPrestige Consumer Healthcare Inc.
PBH		Madrigal Pharmaceuticals, Inc.
MDGL		Indivior Pharmaceuticals, Inc.
INDV		ANI Pharmaceuticals Inc
ANIP
Year ended2026-03-312025-12-312025-12-312025-12-31
Revenue$1.09B$958.40M$1.24B$883.37M
Revenue growth (YoY)-4.3%+432.1%+4.3%+43.8%
Gross margin54.7%n/a80.2%n/a
Operating margin28.4%-31.3%21.1%12.6%
Net margin17.5%-30.1%16.9%8.9%
Net income$190.30M-$288.28M$210.00M$78.34M
EPS (Diluted)$3.91-$12.85$1.64$3.32
Operating cash flow$257.63M-$189.55M-$27.00M$185.22M
Free cash flow$246.45M-$190.02M-$93.00M$171.39M
Cash & equivalents$63.87M$198.69M$195.00M$285.58M
Total assets$3.49B$1.26B$1.20B$1.44B
Total liabilities$1.61B$656.90M$1.30B$899.65M
Shareholders' equity$1.89B$602.69M-$98.00M$540.72M
Return on year-end equity10.1%-47.8%n/a14.5%
Shares outstandingn/a22.84Mn/a22.49M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearPrestige Consumer Healthcare Inc.Madrigal Pharmaceuticals, Inc.Indivior Pharmaceuticals, Inc.ANI Pharmaceuticals Inc
Latest$1.09B
Ended 2026-03-31		$958.40M
Ended 2025-12-31		$1.24B
Ended 2025-12-31		$883.37M
Ended 2025-12-31
1 year earlier$1.14B
Ended 2025-03-31		$180.13M
Ended 2024-12-31		$1.19B
Ended 2024-12-31		$614.38M
Ended 2024-12-31
2 years earlier$1.13B
Ended 2024-03-31		$0
Ended 2023-12-31		$1.09B
Ended 2023-12-31		$486.82M
Ended 2023-12-31
3 years earlier$1.13B
Ended 2023-03-31		$0
Ended 2022-12-31		$901.00M
Ended 2022-12-31		$316.38M
Ended 2022-12-31
4 years earlier$1.09B
Ended 2022-03-31		$0
Ended 2021-12-31		n/a$216.14M
Ended 2021-12-31